May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Ocular Levels of Pigment Epithelium–Derived Factor (PEDF) After Repeated Intraocular or Periocular Injections of Adenovirus–Mediated PEDF.
Author Affiliations & Notes
  • A.–M. Demetriades
    Ophthalmology, Johns Hopkins Hospital, Baltimore, MD
  • T. Deering
    Ophthalmology, Johns Hopkins Hospital, Baltimore, MD
  • Y. Saishin
    Ophthalmology, Johns Hopkins Hospital, Baltimore, MD
  • L. Wei
    GenVec, Inc., Gaithersburg, MD
  • P.A. Campochiaro
    Ophthalmology, Johns Hopkins Hospital, Baltimore, MD
  • Footnotes
    Commercial Relationships  A. Demetriades, None; T. Deering, None; Y. Saishin, None; L. Wei, GenVec, Inc. E; P.A. Campochiaro, GenVec, Inc. R.
  • Footnotes
    Support  EASD–ADA (AD), Knights Templar (AD), BMA JWCA (AD)
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4770. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A.–M. Demetriades, T. Deering, Y. Saishin, L. Wei, P.A. Campochiaro; Ocular Levels of Pigment Epithelium–Derived Factor (PEDF) After Repeated Intraocular or Periocular Injections of Adenovirus–Mediated PEDF. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4770.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To determine if repeated injections of AdPEDF can result in sustained increased levels of PEDF in the eye. Methods: Adult C57BL/6 mice were given periocular (5 x 109 pu) or intravitreous (1 x 109 pu) AdPEDF in the right eye. Mice were euthanized and PEDF levels were measured in ocular tissues at several time points. Repeat injections were performed in some mice on days 28 and 56. Results: (1) Periocular injections. Compared to uninjected mice (n=5), a single injection resulted in a significant increase in PEDF (pg PEDF/µg total protein) at day 3 in sclera (853 vs. 85; p=2x10–6), choroid (623 vs. 64; p=8x10–9) and retina (279 vs. 24; p=0.02). By day 14, increased PEDF levels were present in the sclera (135; p=0.008) and choroid (107; p=0.02), but not the retina (35; p= 0.15). Compared to uninjected mice, a 2nd periocular injection of AdPEDF resulted in significant increase in PEDF at day 3 in sclera (158; p=0.002) and choroid (91; p=0.04), but not the retina (25; p=0.84). By day 14, increased PEDF levels were present only in sclera (368; p=0.002). Compared to uninjected mice, a 3rd injection of AdPEDF resulted in a significant increase in PEDF at day 3 only in sclera (231; p=0.049). (2) Intravitreous injections. Compared to uninjected mice, a single intravitreous injection of AdPEDF resulted in a significant increase in PEDF at days 3 and 14 in sclera (610; 274; p<0.009), choroid (394; 248; p<0.006) and retina (279; 263; p<0.0001). Compared to uninjected mice, a 2nd injection resulted in a significant increase in PEDF at day 3 in sclera (525; p=0.006), choroid (381; p=0.006) and retina (270; p= 0.01). By day 14 there was only a significant increase in retinal PEDF levels (43; p=0.048), but no difference from mice that received a single injection of AdPEDF (47 vs. 43; p=0.6). Compared to uninjected mice, a 3rd injection resulted in a significant increase in PEDF at day 3 in the retina only (58; p=0.01), but no difference by day 14. Conclusions: Repeated intravitreous injections of AdPEDF cause a modest increase in duration of increased levels of PEDF in retina. Repeated periocular injections of AdPEDF do not sustain increased levels of PEDF in retina or choroid. Additional studies are needed to explore the feasibility of repeated injections of AdPEDF via these routes of administration.

Keywords: adenovirus • gene transfer/gene therapy • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×